At a glance
The November 2, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on CMS reimbursement, the College of American Pathologists (CAP) Microbiology Committee perspective, and the FDA.
Format: MP3
Language: English (US)
Size: 25 MB
Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
CMS Reimbursement Update: Sarah Harding, Centers for Medicare & Medicaid Services (CMS)
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value: Daniel Rhoads, Cleveland Clinic
FDA Update: Sara Brenner and Toby Lowe, U.S. Food and Drug Administration (FDA)
Content Source:
Division of Laboratory Systems